Patents by Inventor Dick Fitzgerald

Dick Fitzgerald has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Peptides and compositions thereof for improvement of glycaemic management in a mammal
    Patent number: 10022417
    Abstract: A peptide having 12 to 60 amino acids and including (a) a sequence of SEQUENCE ID NO: 11, or (b) a fragment of SEQUENCE ID NO: 11 that includes the sequence of SEQUENCE ID NO: 1 or 5, is described for use in improving glycemic management in a mammal. A composition, for example a food product, that includes substantially all of the peptides of SEQUENCE ID NO:'s 1 to 11, that is capable of reducing post-prandial blood glucose levels, and increasing insulin secretion in humans, is also described.
    Type: Grant
    Filed: May 12, 2015
    Date of Patent: July 17, 2018
    Assignees: University College Dublin, National University Of Ireland, Dublin, University of Limerick
    Inventors: Lorraine Brennan, Aisling Robinson, Nessa Noronha, Dick Fitzgerald, Alice Nongonierma, Therese Holton, Helen Roche, J C Jacquier, Denis Shields, Eileen Gibney
  • Peptides and Compositions Thereof for Improvement of Glycaemic Management in a Mammal
    Publication number: 20170112890
    Abstract: A peptide having 12 to 60 amino acids and including (a) a sequence of SEQUENCE ID NO: 11, or (b) a fragment of SEQUENCE ID NO: 11 that includes the sequence of SEQUENCE ID NO: 1 or 5, is described for use in improving glycemic management in a mammal. A composition, for example a food product, that includes substantially all of the peptides of SEQUENCE ID NO:'s 1 to 11, that is capable of reducing post-prandial blood glucose levels, and increasing insulin secretion in humans, is also described.
    Type: Application
    Filed: May 12, 2015
    Publication date: April 27, 2017
    Inventors: Lorraine Brennan, Aisling Robinson, Nessa Noronha, Dick Fitzgerald, Alice Nongonierma, Therese Holton, Helen Roche, JC Jacquier, Denis Shields, Eileen Gibney
  • CASEIN HYDROLYSATE
    Publication number: 20170037442
    Abstract: A casein hydrolysate formed by controlled hydrolysis of a casein substrate by an aspergillus-derived (fugal) proteolytic preparation is described. The controlled hydrolysis employs a FlavorPro-Whey™ formulation and a degree of hydrolysis (% DH) of from 5% DH to 15% DH. The Hydrolysate has at least a 98% reduction in antigenicity compared to intact sodium caseinate and a mean bitterness score of less than 30%. The invention also provides a low molecular weight fraction of casein hydrolysate of the invention which is substantially free of peptides having a molecular weight greater than 5 kDa.
    Type: Application
    Filed: October 6, 2015
    Publication date: February 9, 2017
    Applicant: UNIVERSITY OF LIMERICK
    Inventors: Dick Fitzgerald, Dara O'Sullivan
  • CASEIN HYDROLYSATE
    Publication number: 20140213762
    Abstract: A casein hydrolysate formed by controlled hydrolysis of a casein substrate by an aspergillus-derived (fugal) proteolytic preparation is described. The controlled hydrolysis employs a FlavorPro-Whey™ formulation and a degree of hydrolysis (% DH) of from 5% DH to 15% DH. The hydrolysate has at least a 98% reduction in antigenicity compared to intact sodium caseinate and a mean bitterness score of less than 30%.
    Type: Application
    Filed: February 17, 2012
    Publication date: July 31, 2014
    Applicant: UNIVERSITY OF LIMERICK
    Inventors: Dick Fitzgerald, Dara O'Sullivan
  • PROTEIN PRODUCT FOR MODIFYING CARDIOVASCULAR HEALTH
    Publication number: 20110130637
    Abstract: A composition for use in the treatment or prophylaxis of conditions mediated by endothelial function in mammals is provided. The composition includes a milk protein hydrolysate generated by treating milk or milk whey protein with a proteolytic enzyme having subtilisin or subtilisin-like activity and/or glutamyl endopeptidase or glutamyl endopeptidase-like activity. The composition is useful in the management of vascular conditions.
    Type: Application
    Filed: March 19, 2009
    Publication date: June 2, 2011
    Applicant: University of Dundee
    Inventors: Dick Fitzgerald, Allan Struthers
  • PROTEIN PRODUCT WITH MODIFIED ANTIGENICITY
    Publication number: 20100305050
    Abstract: A bovine casein protein hydrolysate prepared using an enzyme having broad spectrum endopeptidase activity has low residual antigenicity properties in mammals compared to intact casein protein, The composition is useful as an ingredient in foods, beverages, pharmaceutical and cosmetic products. A hydrolysate prepared using Alcalase™ with a degree of hydrolysis of 19.88% has very desirably low antigenicity characteristics.
    Type: Application
    Filed: June 2, 2010
    Publication date: December 2, 2010
    Applicant: University of Limerick
    Inventors: Dick Fitzgerald, Ebenezer Rajarathnam, Dara O'Sullivan